Please upgrade your browser.
Decision Resources, one of the worlds leading research and advisory firms for pharmaceutical and healthcare issues, finds that the renal cell carcinoma drug market will experience robust 3.7 percent annual growth from 2010 to 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
New approaches to kidney cancer research explored
Afinitor is also used in the treatment of advanced kidney cancer
Mohammad Kazem Moslemia, Mehdi Abedinzadehb
Pfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer.
Dr. Vogelzang is a founding member and director of the Kidney Cancer Association.
A Business Week Article gives the appearance that FDA might not like this drug, but is it effectiveness or cost that is driving this? FDA recently pulled its approval for Avastin in breast cancer, a drug also used to treat advanced kidney cancer. Some critics thought the cost of the therapy was really at issue.
This fusion protein was capable of inducing DC maturation and interleukin (IL)-12 production in DCs. Interaction of DCs pulsed with CA9-AbOmpA fusion proteins with naive T cells stimulated secretion of IL-2, interferon (IFN)-γ and tumour necrosis factor (TNF)-α in T cells.
What's it like to be a young adult diagnosed with kidney cancer?
The final broadcast of Kidney Cancer News for 2011 examines the importance of advanced surgical techniques in the treatment of renal cancers. It features Dr. Matin who spoke at the Kidney Cancer Association's National Patients and Survivors Conference held in Houston at M. D. Anderson Cancer Center.
|Powered by NeonCRM|